LifeVantage Corporation announced that it has been granted U.S. Patent No. 12,589,067 B2 for its Healthy Glow Essentials Stack, a nutraceutical blend that combines Protandim® Nrf2 Synergizer® and TrueScience® Liquid Collagen. The patent, issued on March 31 2026, protects the specific composition and the methods for activating cellular signaling genes that underpin the stack’s skin‑health and anti‑aging benefits, giving LifeVantage exclusive rights to market and license the formulation in the United States.
The grant of this patent is a strategic milestone for LifeVantage’s “Activation” portfolio. By securing intellectual‑property protection for a formulation that demonstrates synergistic activation of cellular signaling pathways, the company reinforces its science‑driven brand and creates a defensible barrier against competitors who might otherwise replicate the product. The patent also positions LifeVantage to pursue licensing opportunities and to expand the stack’s commercial reach without the risk of copycat products eroding market share.
LifeVantage’s recent financial performance provides context for the significance of the patent. In fiscal 2025, the company reported revenue of $55.1 million, a 12.6% year‑over‑year increase, and earnings per diluted share of $0.15. In the first quarter of fiscal 2026, revenue fell to $47.6 million, a 0.7% year‑over‑year rise, with EPS of $0.17. Management has guided fiscal 2026 revenue to $225 million–$240 million and adjusted EBITDA to $23 million–$26 million, reflecting confidence in continued growth while acknowledging the need for disciplined cost management. The company also completed the acquisition of LoveBiome and announced a CEO transition from Steve Fife to Terrence Moorehead, signaling a strategic shift toward broader health‑tech integration.
Steve Fife, LifeVantage’s President and CEO, noted that the company’s “Fourth quarter results capped off a strong fiscal 2025 as we delivered revenue growth of approximately 13% to $55.1 million, expanded gross margin and increased earnings.” Vice President of Research and Development Lisa Barnes added, “Receiving this U.S. patent for Healthy Glow Essentials Stack™ is the culmination of over three years of rigorous research and development. Our team discovered powerful synergies through systematic testing of Activator pairings. This patent further validates our science‑driven approach and reinforces LifeVantage’s position as an innovation leader in the industry.”
The patent strengthens LifeVantage’s competitive position in the nutrigenomics market by providing a defensible IP moat around a product that aligns with growing consumer demand for skin‑health and anti‑aging solutions. It also enhances the company’s ability to generate future revenue streams through direct sales, licensing, and potential collaborations with other health‑tech firms. By protecting the unique combination of Protandim® and TrueScience® Liquid Collagen, LifeVantage can continue to invest in R&D, expand its product line, and pursue strategic acquisitions such as LoveBiome to broaden its health‑tech ecosystem.
In summary, the U.S. patent for the Healthy Glow Essentials Stack represents a key intellectual‑property achievement that underpins LifeVantage’s growth strategy, supports its financial outlook, and reinforces its leadership in the nutrigenomics space. The milestone is expected to provide long‑term competitive advantage and open new avenues for product development and market expansion.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.